In order to access this content you must be logged in and have a subscription to PL Intelligence.
PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Fujisawa will Dissolve its Subsidiary for Product Distribution
Suzuken Co., Ltd Invests in Glucon
Tularik begins GPCR drug discovery collaboration with Sankyo
Cyclacel announces in-licensing of phase I anticancer drug from Sankyo
Biota secures global influenza partnership with Sankyo
Metabasis and Sankyo extend diabetes collaboration
Sankyo gains rights to cholesterol lowering agent
Japan's Sankyo licenses Roche for new antibiotic
Sankyo and Fujisawa Agree to Discontinue Business Arrangements on Sankyo's Antifungal CS-758
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
